#VisualAbstract: Rituximab plus lenalidomide shows comparable survival compared to chemotherapy for CD20⁺ follicular lymphoma
Click to read this study in the Journal of Clinical Oncology.
Read MoreOct 21, 2022
Click to read this study in the Journal of Clinical Oncology.
Read MoreOct 21, 2022
1. 4-year recurrence-free survival was significantly higher with nivolumab plus ipilimumab...
Read MoreOct 15, 2022
Click to read this study in the Journal of Clinical Oncology.
Read MoreOct 15, 2022
1. In this randomized controlled trial, treatment of acute pyelonephritis and complicated urinary...
Read MoreOct 15, 2022
1. The composite of MRI-detected brain infarcts and symptomatic ischemic stroke was comparable...
Read MoreOct 11, 2022
1. Dapagliflozin was shown to reduce the risk of disease progression and cardiovascular death in...
Read MoreOct 11, 2022
Click to read this study in the Journal of Clinical Oncology.
Read MoreOct 11, 2022
1. In this randomized controlled trial, in participants with problem alcohol use, individuals in...
Read MoreOct 11, 2022
Click here to read this study in JAMA.
Read MoreOct 11, 2022
Click here to read this study in JAMA.
Read MoreSep 28, 2022
Click to read this study in Clinical Cancer Research.
Read MoreSep 28, 2022
1. Adjuvant pembrolizumab significantly improved disease-free survival in comparison to placebo in...
Read MoreSep 28, 2022
Click here to read this study in NEJM.
Read MoreSep 22, 2022
Click to read this study in the Journal of Clinical Oncology.
Read MoreSep 15, 2022
1. Amongst patients aged 70 or older, screening for atrial fibrillation with an implantable loop...
Read MoreSep 14, 2022
1. In high-risk patients who had undergone percutaneous coronary intervention (PCI), routine...
Read MoreSep 9, 2022
1. Older adults treated with nirmatrelvir were significantly less likely to be hospitalized for...
Read MoreSep 9, 2022
1. In this random1. In this randomized controlled trial that included 9711 patients...
Read MoreSep 6, 2022
Click here to read this study in NEJM.
Read MoreSep 6, 2022
Click here to read this study in JAMA.
Read More